Clinical Trial Update: Ketamine Infusion for Comorbid PTSD and Chronic Pain [Phase 3]

View source ↗

Summary

Phase 3 trial update on ketamine infusion for comorbid PTSD and chronic pain has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain
• Post-traumatic Stress Disorder

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: VA Ann Arbor Healthcare System | Conditions: PTSD, Chronic Pain | Phase 3 | Status: COMPLETED | Results posted: 2020-12-22